scholarly article | Q13442814 |
P50 | author | Maria Debiec-Rychter | Q66809340 |
Vanessa Vanspauwen | Q66809394 | ||
Raf Sciot | Q66809432 | ||
Joanna Przybyl | Q117228165 | ||
Ignace Samson | Q117265825 | ||
Piotr Rutkowski | Q125623002 | ||
Janusz A Siedlecki | Q59559026 | ||
P2860 | cites work | Translocations involving the X chromosome in solid tumors: presentation of two sarcomas with t(X;18)(q13;p11) | Q68733627 |
Translocation X;18 in synovial sarcoma | Q70145818 | ||
Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma | Q73821343 | ||
A novel type of SYT/SSX fusion: methodological and biological implications | Q74302601 | ||
Re: A novel fusion gene, SYT-SSX4, in synovial sarcoma | Q74459625 | ||
Characterization of a variant SYT-SSX1 synovial sarcoma fusion transcript | Q78173995 | ||
Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan | Q80509742 | ||
A novel variant of SYT-SSX1 fusion gene in a case of spindle cell synovial sarcoma | Q80847758 | ||
Molecular characterization of a novel variant of a SYT-SSX1 fusion transcript in synovial sarcoma | Q81322396 | ||
Correlates of SYT-SSX fusion type in synovial sarcoma: getting more complex but also more interesting? | Q81771941 | ||
Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma | Q24307456 | ||
The central proline rich region of POB1/REPS2 plays a regulatory role in epidermal growth factor receptor endocytosis by binding to 14-3-3 and SH3 domain-containing proteins | Q24316124 | ||
Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors | Q24534185 | ||
Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript | Q24684124 | ||
A novel fusion gene, SYT-SSX4, in synovial sarcoma. | Q27777797 | ||
Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. | Q27824779 | ||
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma | Q27851510 | ||
Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression | Q28190079 | ||
A novel fusion gene, SS18L1/SSX1, in synovial sarcoma | Q28191167 | ||
REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells | Q30938786 | ||
Clinical impact of molecular and cytogenetic findings in synovial sarcoma | Q34082692 | ||
Identification of REPS2 as a putative modulator of NF-kappaB activity in prostate cancer cells | Q34325532 | ||
EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2. | Q34354134 | ||
Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis | Q34550816 | ||
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms | Q35125621 | ||
SYT-SSX fusion genes and prognosis in synovial sarcoma. | Q36623165 | ||
Reps2: a cellular signaling and molecular trafficking nexus | Q37930200 | ||
A variant of the SYT-SSX2 fusion gene in a case of synovial sarcoma | Q40282488 | ||
A new human synovial sarcoma cell line, HS-SY-3, with a truncated form of hybrid SYT/SSX1 gene | Q40806404 | ||
t(X;18) reverse transcriptase-polymerase chain reaction demonstrating a variant transcript | Q42720854 | ||
TMEM25, REPS2 and Meis 1: favourable prognostic and predictive biomarkers for breast cancer | Q43272255 | ||
Novel SYT-SSX fusion transcript variants in synovial sarcoma | Q44749236 | ||
The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. | Q44785118 | ||
A novel FISH assay for SS18-SSX fusion type in synovial sarcoma | Q47314970 | ||
Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma | Q47963548 | ||
Detection of a variant SYT-SSX1 fusion in a case of predominantly epithelioid synovial sarcoma. | Q53682869 | ||
P433 | issue | 6 | |
P921 | main subject | synovial sarcoma | Q2619315 |
P304 | page(s) | 2245-2253 | |
P577 | publication date | 2012-09-14 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases | |
P478 | volume | 33 |
Q47927686 | BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfall |
Q92980126 | Clinical application of RNA sequencing in sarcoma diagnosis: An institutional experience |
Q41617073 | Detailed analysis of a superficial CD34-positive fibroblastic tumor: A case report and review of the literature |
Q93164602 | Diagnostic Value of TLE1 in Synovial Sarcoma: A Systematic Review and Meta-Analysis |
Q55408540 | Intraneural synovial sarcoma of the tibial nerve. |
Q38153685 | Primary monophasic synovial sarcoma of the kidney: a case report and review of literature |
Q39233440 | Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy. |
Q38567366 | Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer |
Search more.